Search results for "Antibacterial agent"

showing 9 items of 169 documents

Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

2000

ABSTRACT We conducted a quantitative structure-activity relationship study using a database of 158 quinolones previously tested against Mycobacterium avium-M. intracellulare complex in order to develop a model capable of predicting the activity of new quinolones against the M. avium-M. intracellulare complex in vitro. Topological indices were used as structural descriptors and were related to anti- M. avium-M. intracellulare complex activity by using the linear discriminant analysis (LDA) statistical technique. The discriminant equation thus obtained correctly classified 137 of the 158 quinolones, including 37 of a test group of 44 randomly chosen compounds. This model was then applied to 2…

medicine.drug_classStereochemistryComputational biologyModels BiologicalStructure-Activity RelationshipAnti-Infective AgentsMoxifloxacinPredictive Value of TestsmedicinePharmacology (medical)Computer SimulationMechanisms of Action: Physiological EffectsAntibacterial agentPharmacology4-QuinolonesbiologyLinear discriminant analysisbiology.organism_classificationQuinoloneMycobacterium avium ComplexGatifloxacinInfectious DiseasesSparfloxacinMolecular topologymedicine.drugMycobacteriumAntimicrobial agents and chemotherapy
researchProduct

Anti- Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Te…

2000

ABSTRACT The apicoplast, a plastid-like organelle of Toxoplasma gondii , is thought to be a unique drug target for quinolones. In this study, we assessed the in vitro activity of quinolones against T. gondii and developed new quantitative structure-activity relationship models able to predict this activity. The anti- Toxoplasma activities of 24 quinolones were examined by means of linear discriminant analysis (LDA) using topological indices as structural descriptors. In parallel, in vitro 50% inhibitory concentrations (IC 50 s) were determined in tissue culture. A multilinear regression (MLR) analysis was then performed to establish a model capable of classifying quinolones by in vitro acti…

medicine.drug_classStereochemistryMolecular ConformationBiologyModels BiologicalStructure-Activity RelationshipAnti-Infective AgentsPredictive Value of TestsMoxifloxacinparasitic diseasesmedicineAnimalsStructure–activity relationshipComputer SimulationPharmacology (medical)Mechanisms of Action: Physiological EffectsAntibacterial agentPharmacology4-QuinolonesBiological activityQuinoloneGatifloxacinGrepafloxacinTrovafloxacinInfectious DiseasesRegression AnalysisToxoplasmaFluoroquinolonesmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Interventionelle ERCP bei Patienten mit Cholestase: Häufigkeit und Antibiotikaresistenz der biliären Keimbesiedlung

2001

Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance. Biliary obstruction together with bacterial colonization of the bile duct may lead to development of acute cholangitis. The aim of our prospective study was to investigate the presence and degree of biliary bacterial colonization by means of bile aspiration during ERCP in patients with biliary obstruction. Furthermore, we evaluated antibiotic therapy regimens, which would cover the bacterial species obtained by ERCP and subsequent culture in each patient. In addition, analysis of risk factors was performed that would predispose to the development of cholangitis.80 patients w…

medicine.medical_specialtyBile ductbusiness.industryGastroenterologymedicine.diseasedigestive systemGastroenterologydigestive system diseasesMetronidazolemedicine.anatomical_structureCholestasisLevofloxacinBacteremiaInternal medicinemedicineCeftriaxoneAnaerobic bacteriabusinessmedicine.drugAntibacterial agentZeitschrift für Gastroenterologie
researchProduct

The impact of antibiotic resistance on the efficacy of three 7-day regimens againstHelicobacter pylori

2000

Background: Antibiotic resistance affects the success of anti-Helicobacter pylori therapies and varies greatly from country to country. Aim: To compare the efficacy of three short-term triple regimens in relation to H. pylori primary resistance in our region. Methods: We enrolled 210 H. pylori-positive dyspeptic patients for this randomized, open, parallel-group study. Three arms of 70 patients each received the following 1-week regimens: (1) ranitidine bismuth citrate 400 mg b.d. + clarithromycin 250 mg b.d. + metronidazole 500 mg b.d. (RCM); (2) bismuth subcitrate 240 mg b.d. + amoxycillin 1000 mg b.d. + metronidazole 500 mg b.d. (BAM); (3) omeprazole 20 mg o.d. + clarithromycin 250 mg b.…

medicine.medical_specialtyHepatologybiologybusiness.industryGastroenterologyDrug resistanceHelicobacter pyloriAmoxicillinbiology.organism_classificationGastroenterologySurgeryMetronidazoleBismuth SubcitrateClarithromycinInternal medicinemedicinePharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori

1999

Background : Triple therapies containing omeprazole and ranitidine have been shown to be equivalent in eradicating H. pylori infection, but have been assessed either separately or head-to-head, only in small trials. Aim : To carry out a large randomized controlled study comparing omeprazole and ranitidine combined with two antibiotic combinations for 1 week. Methods : Three hundred and twenty H. pylori-positive patients were randomly subdivided into four equal-sized groups and received one of the following treatments: OAM = omeprazole 20 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; RAM = ranitidine 300 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; OAC = omeprazo…

medicine.medical_specialtyHepatologybiologymedicine.drug_classbusiness.industrySpirillaceaeAntibioticsGastroenterologyProton-pump inhibitorHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineClarithromycinInternal medicinemedicinePharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and…

1997

We have tested whether tetracyclines (TETs) are able to protect mice from lipopolysaccharide (LPS)-induced shock, a cytokine-mediated inflammatory reaction. Mice, injected with a single dose of tetracycline base (TETb; 1.5, 10 and 20 mg/kg of body weight) or doxycycline (DOXY; 1.5 mg/kg), were significantly protected from a lethal intraperitoneal injection of LPS (500 micrograms per mouse). TETs acted in early events triggered in response to LSP; in fact, they were no longer significantly protective if injected more than 1 h after the injection of endotoxin. LPS-treated mice protected by TETs showed a significant inhibition of tumor necrosis factor alpha (TNF-alpha), interleukin-1 alpha (IL…

medicine.medical_specialtyLipopolysaccharidemedicine.medical_treatmentIntraperitoneal injectionDown-RegulationAlpha (ethology)SpleenBiologyMicechemistry.chemical_compoundInternal medicinemedicineAnimalsPharmacology (medical)LungAntibacterial agentPharmacologyMice Inbred BALB CNitratesTumor Necrosis Factor-alphaTetracyclineShock SepticEndotoxemiaAnti-Bacterial AgentsNitric oxide synthaseInfectious DiseasesEndocrinologyCytokinemedicine.anatomical_structurechemistryDoxycyclineEnzyme InductionMacrophages Peritonealbiology.proteinCytokinesFemaleTumor necrosis factor alphaNitric Oxide SynthaseInjections IntraperitonealSpleenInterleukin-1Research ArticleAntimicrobial Agents and Chemotherapy
researchProduct

Selective Chemical Vestibulectomy

1997

In an attempt to destroy the peripheral vestibular labyrinth selectively in patients suffering from intractable vertigo as a result of end-stage Meniere’s disease, 25 patients underwent selective chem

medicine.medical_specialtybiologybusiness.industrymedicine.diseasebiology.organism_classificationSurgeryMENIERE DISEASEOtorhinolaryngologyVertigoVestibular labyrinthotorhinolaryngologic diseasesmedicineIn patientsense organsbusinessMeniere's diseaseAntibacterial agentORL
researchProduct

[Antimicrobically coated venous catheters--must? Contra].

2002

medicine.medical_specialtymedicine.drug_classAntibioticsMEDLINEDrug resistanceCritical Care and Intensive Care MedicineCatheterizationAnti-Infective AgentsmedicineHumansIntensive care medicineVeinAntibacterial agentbusiness.industryDrug Resistance MicrobialGeneral MedicineBacterial InfectionsSurgeryCatheterAnesthesiology and Pain Medicinemedicine.anatomical_structureEmergency MedicineAnti-Infective Agents LocalAnti-Infective AgentsbusinessComplicationAnasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
researchProduct

Chemical composition and antimicrobial activity of the essential oil from aerial parts of Micromeria fruticulosa (Bertol.) Grande (Lamiaceae) growing…

2007

The essential oil of aerial parts of Micromeria fruticulosa (Lamiaceae) growing wild in Southern Italy was obtained by hydrodistillation and analysed by GC and GC–MS. Sixty-one compounds, representing 91.3% of the oil, were identified. The major components were γ-terpinene (14.5%), β-caryophyllene (12.6%), p-cymene (8.9%), α-pinene (8.2%) and β-bisabolene (7.2%). The essential oil showed action mainly against Gram-positive bacteria. Copyright © 2007 John Wiley & Sons, Ltd.

p-CymenebiologyCaryophylleneGeneral Chemistrybiology.organism_classificationTerpenoidlaw.inventionMicromeriaSteam distillationchemistry.chemical_compoundchemistrylawBotanyLamiaceaeEssential oilFood ScienceAntibacterial agent
researchProduct